RT @AnnSurgOncol: NOVEMBER ISSUE: Early Recurrence in Completely #ResectedIIIB and IIIC #Melanoma Warrants Restaging Prior to #AdjuvantTher…
RT @AnnSurgOncol: NOVEMBER ISSUE: Early Recurrence in Completely #ResectedIIIB and IIIC #Melanoma Warrants Restaging Prior to #AdjuvantTher…
RT @AnnSurgOncol: NOVEMBER ISSUE: Early Recurrence in Completely #ResectedIIIB and IIIC #Melanoma Warrants Restaging Prior to #AdjuvantTher…
We know surgery and anaesthesia can have immunosuppressive effects. Melanoma is one of the most immunogenic tumours. Makes me wonder if neoadjuvant approach is best in these high risk patients - looking forward to that data.
RT @AnnSurgOncol: NOVEMBER ISSUE: Early Recurrence in Completely #ResectedIIIB and IIIC #Melanoma Warrants Restaging Prior to #AdjuvantTher…
RT SocSurgOnc RT AnnSurgOncol: NOVEMBER ISSUE: Early Recurrence in Completely #ResectedIIIB and IIIC #Melanoma Warrants Restaging Prior to #AdjuvantTherapy. https://t.co/X5p2YwuDgL McMastersKelly SocSurgOnc https://t.co/NxIERUbDse
RT @AnnSurgOncol: NOVEMBER ISSUE: Early Recurrence in Completely #ResectedIIIB and IIIC #Melanoma Warrants Restaging Prior to #AdjuvantTher…
RT @AnnSurgOncol: NOVEMBER ISSUE: Early Recurrence in Completely #ResectedIIIB and IIIC #Melanoma Warrants Restaging Prior to #AdjuvantTher…
NOVEMBER ISSUE: Early Recurrence in Completely #ResectedIIIB and IIIC #Melanoma Warrants Restaging Prior to #AdjuvantTherapy. https://t.co/y9YN7WmKBf @McMastersKelly @SocSurgOnc https://t.co/IN0qtqePST
RT @TumImmTx_papers: Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy. https://t…